Stocksigma LogoStocksigma Logo

Curis Lifesciences Confirms Corporate Governance Report Exemption for Q2 FY27

Curis Lifesciences Limited has confirmed the non-applicability of Corporate Governance Report submission under Regulation 27(2) of SEBI LODR Regulations

Curis Lifesciences Confirms Corporate Governance Report Exemption for Q2 FY27

Curis Lifesciences Ltd 路 Others (Uncategorized) 路 19 Oct 2026, 10:22 pm

Curis Lifesciences Confirms Corporate Governance Report Exemption for Q2 FY27 Curis Lifesciences Limited has confirmed the non-applicability of Corporate Governance Report submission under Regulation 27(2) of SEBI LODR Regulations for the quarter and half-year ended 30th Sep'26. Being listed on the NSE SME platform (NSE Emerge), the company is exempt under Regulation 15(2)(b) from key corporate governance provisions, excluding Regulation 23 compliance where applicable. A practicing company secretary certificate from Sachin Thakkar & Associates has been submitted confirming this regulatory exemption.

Original exchange filing (PDF)

More announcements from Curis Lifesciences Ltd

All Curis Lifesciences Ltd announcements